Who owns INOZYME PHARMA INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Inozyme Pharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Inozyme Pharma stock

Who bought or sold INOZYME PHARMA INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Adage Capital Partners GP 5.5M $23M 30% Sep 2023
 View chart
Pivotal bioVenture Partners Investment Advisor 4.5M $19M 23% Sep 2023
 View chart
Sofinnova Ventures 4.3M $18M 17% Sep 2023
 View chart
Rock Springs Capital Management 3.7M $16M 7% Sep 2023
 View chart
Samlyn Capital 3.4M $14M 4% Dec 2023
 View chart
Eventide Asset Management 3.2M $14M 2% Dec 2023
 View chart
FMR 2.5M $10M 229% Sep 2023
 View chart
NEA Management Company 2.4M $10M 0% Dec 2023
 View chart
Vanguard Group 2.4M $10M 5% Dec 2023
 View chart
BlackRock 2.2M $9.4M 15% Sep 2023
 View chart
Sphera Funds Management 1.6M $6.7M 27% Dec 2023
 View chart
Samsara BioCapital 1.6M $6.7M 0% Dec 2023
 View chart
Affinity Asset Advisors 1.4M $5.8M 84% Sep 2023
 View chart
Blue Owl Capital Holdings 1.3M $5.4M 100% Dec 2023
 View chart
CHI Advisors 1.3M $5.3M 6% Sep 2023
 View chart
Millennium Management 912k $3.9M -31% Dec 2023
 View chart
Geode Capital Management 823k $3.5M 33% Sep 2023
 View chart
State Street Corporation 628k $2.6M 12% Sep 2023
 View chart
Laurion Capital Management 557k $2.4M -18% Dec 2023
 View chart
Knott David M Jr 454k $1.9M 106% Sep 2023
 View chart
Octagon Capital Advisors 400k $1.7M -69% Dec 2023
 View chart
Goldman Sachs Group 363k $1.5M 574% Dec 2023
 View chart
Northern Trust 335k $1.4M 11% Sep 2023
 View chart
MPM Oncology Impact Management 327k $1.4M 0% Sep 2023
 View chart
Renaissance Technologies 296k $1.2M 24% Sep 2023
 View chart
Kennedy Capital Management 288k $1.2M 100% Dec 2023
 View chart
Susquehanna International 254k $1.1M 349% Sep 2023
 View chart
Overbrook Management Corp. 219k $934k 0% Dec 2023
 View chart
Parkman Healthcare Partners 176k $739k 4% Sep 2023
 View chart
Citadel Advisors 175k $745k 3% Dec 2023
 View chart
GSA Capital Partners 167k $711k 80% Dec 2023
 View chart
Bank of New York Mellon 158k $673k 12% Dec 2023
 View chart
UBS O'Connor 155k $652k 0% Sep 2023
 View chart
Nuveen Asset Management 138k $579k 0% Sep 2023
 View chart
Superstring Capital Management 124k $528k 100% Dec 2023
 View chart
Charles Schwab Investment Management 122k $518k 29% Dec 2023
 View chart
Schonfeld Strategic Advisors 109k $463k -65% Dec 2023
 View chart
Bridgeway Capital Management 92k $385k -21% Sep 2023
 View chart
Bank of America Corporation 79k $335k -19% Dec 2023
 View chart
Two Sigma Advisers 71k $301k -26% Dec 2023
 View chart
Barclays 69k $295k 650% Dec 2023
 View chart
Dimensional Fund Advisors 64k $271k 7% Dec 2023
 View chart
Rhumbline Advisers 60k $257k 31% Dec 2023
 View chart
Two Sigma Investments 54k $229k -21% Dec 2023
 View chart
Jane Street 51k $219k 100% Dec 2023
 View chart
UBS Group 46k $197k 144% Dec 2023
 View chart
AQR Capital Management 46k $196k 133% Dec 2023
 View chart
ALPS Advisors 42k $180k 100% Dec 2023
 View chart
Jpmorgan Chase & Co 34k $147k 56% Dec 2023
 View chart
Virtu Financial 27k $114k 154% Dec 2023
 View chart
MetLife Investment Advisors 27k $113k 47% Dec 2023
 View chart
Morgan Stanley 26k $111k -21% Sep 2023
 View chart
American International 24k $101k 40% Dec 2023
 View chart
Denali Advisors 22k $94k -18% Dec 2023
 View chart
Bank Of Montreal 22k $99k 100% Dec 2023
 View chart
SG Americas Securities 21k $90k 47% Dec 2023
 View chart
Alliancebernstein 18k $78k 0% Dec 2023
 View chart
American Century Companies 18k $76k 48% Sep 2023
 View chart
Deutsche Bank Aktiengesellschaft 16k $69k 0% Dec 2023
 View chart
Parallel Advisors 16k $68k 3% Dec 2023
 View chart
Royal Bank of Canada 15k $65k 166% Dec 2023
 View chart
Wells Fargo & Company 15k $63k 74% Dec 2023
 View chart
Manufacturers Life Insurance Company 15k $61k -1% Sep 2023
 View chart
Values First Advisors 14k $59k 100% Dec 2023
 View chart
Ing Investment Management 14k $58k 0% Sep 2023
 View chart
New York State Common Retirement Fund 13k $57k -1% Dec 2023
 View chart
Invesco 13k $55k 0% Sep 2023
 View chart
T. Rowe Price Associates 13k $55k 100% Dec 2023
 View chart
Florida State Board of Administration 12k $53k 100% Dec 2023
 View chart
Tower Research Capital 8.3k $35k 134% Sep 2023
 View chart
California State Teachers Retirement System 7.5k $31k -34% Sep 2023
 View chart
Citigroup 6.7k $27k 37350% Dec 2023
 View chart
Summit Investment Advisors 4.8k $21k 72% Dec 2023
 View chart
Legal & General Group 4.0k $17k 35% Dec 2023
 View chart
Amalgamated Bank 3.0k $13k -10% Dec 2023
 View chart
Metropolitan Life Insurance Company 2.9k $12k 54% Dec 2023
 View chart
Group One Trading 1.0k $4.2k -52% Sep 2023
 View chart
Advisor Group Holdings 50.00 $213.000000 0% Dec 2023
 View chart

Who sold out of Inozyme Pharma?

Fund or Company Name Date Sold Shares Held Valued At
Deep Track Capital Jun 2023 1.6M $9.2M
Point72 Asset Management Sep 2023 700k $2.9M
Woodline Partners Jun 2023 289k $1.6M
Eudaimonia Asset Management Jun 2023 176k $982k
Marshall Wace Sep 2023 136k $570k
Acadian Asset Management Jun 2023 58k $319k
Mirae Asset Global Investments Sep 2023 55k $233k
Squarepoint Ops Sep 2023 43k $179k
Walleye Trading Advisors Sep 2023 35k $147k
ExodusPoint Capital Management Jun 2023 22k $123k
OTR - Nominee Name for The State Teachers Retirement Board of Ohio Sep 2023 9.9k $41k
Dorsey Wright & Associates Jun 2023 3.4k $19k
Simplex Trading Sep 2023 1.0k $4.0k
Goss Wealth Management Jun 2023 381.00 $2.1k
Us Bancorp Sep 2023 129.00 $542.006400